ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1797

Seasonal Differences in the Disease Onset and the Exacerbation of Systemic Lupus Erythematosus

Takehisa Ogura1, Ayako Hirata1, Sayaka Takenaka2, Hideki Ito2, Yuki Fujisawa1, Norihide Hayashi2, Rie Kujime1, Munetugu Imamura2, Kennosuke Mizushina1, Takaharu Katagiri2 and Hideto Kameda1, 1Department of Rheumatology, Toho University Ohashi Medical Center, Tokyo, Japan, 2Toho University Ohashi Medical Center, Tokyo, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Environmental factors and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster II: Damage Accrual and Quality of Life

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  It has been well acknowledged that both genetic and environmental factors are important in the pathogenesis of systemic lupus erythematosus (SLE). To elucidate the environmental factors associated with SLE pathogenesis, we investigated the seasonal differences in the disease onset and the exacerbation of SLE.

Methods: In the present study, we retrospectively reviewed the medical records of 122 patients with SLE (88.5% female and the average age of 43 years) fulfilling the 1997 revised ACR classification criteria. The mean observation period was 7.2 years. The disease exacerbation was defined as either a new appearance of clinical manifestations of SLE or the clinical condition requiring the start or dose increment of glucocorticoids by at least 50%.

Results: The disease onset was the most frequently observed in Spring (31.0%) and the least in Fall (16.1%). A total of 167 disease exacerbations were observed among 879 patient-years, and more interestingly, the disease exacerbation was significantly more frequently observed in Spring (38.3%) and significantly less frequently observed in Fall (10.8%) as compared with other seasons. It should be noted that the both disease onset (0.0%) and exacerbation (2.4%) of SLE were the least in September. Disease manifestation at the exacerbation was similar throughout the seasons, and 60.0% of the disease exacerbation did not accompany serological activity defined by the increase in anti-DNA antibody or the decrease in complement activity.

Conclusion: Concordant seasonal differences between the disease onset and the exacerbation implicated the crucial role of environmental factors in the pathogenesis of SLE, possibly through the activation of innate immune systems.


Disclosure: T. Ogura, None; A. Hirata, None; S. Takenaka, None; H. Ito, None; Y. Fujisawa, None; N. Hayashi, None; R. Kujime, None; M. Imamura, None; K. Mizushina, None; T. Katagiri, None; H. Kameda, None.

To cite this abstract in AMA style:

Ogura T, Hirata A, Takenaka S, Ito H, Fujisawa Y, Hayashi N, Kujime R, Imamura M, Mizushina K, Katagiri T, Kameda H. Seasonal Differences in the Disease Onset and the Exacerbation of Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/seasonal-differences-in-the-disease-onset-and-the-exacerbation-of-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/seasonal-differences-in-the-disease-onset-and-the-exacerbation-of-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology